1David A. H om ocysteine ve cholesterol competing views, or a unifying explanation of arteriosclerotic cardiovascular disease [ J ]. Lab Med, 1998,29:410-417.
2Hyland K, Bottiglieri T. Measurement of total plasma and cerebrospinal fluid homocysteine by fluorescence following highperformance liquid chromatography and precolumn derivatization with ophthaldialdehyde. J Chromatogr, 1992,579:55-62.
3Kang ss,Wrong P WK, Malinow MR. Hyperhomocysteine mia as a risk factor occlusive vascular disease [ J ]. Ann Rev Nutr, 1992, 12:279-298.
4StangerO, WegerM. Interactions ofhomocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium [ J ]. ClinChem LabMed, 2003, 41 ( 11 ) : 1444-1454.
5Welch GN, Upchurch GR Jr, Loscalzo Z. Homocysteine, oxidative stress and vascular disease. Hosp Pract, 1997,32:81-92.
6Nagai Y, Tasaki H, Takatsu H, et al. Homocysteine inhibitisangiogenesis in vitro and in vivo. Biochem Biophys Res Commun, 2001,281:726-731.
7KartalOzerN, NegisY, AytanN. Molecularmechanisms of cholesterolorhomocysteine effect in the developmentofatherosclerosis: roleof vitamin E[J]. Biofactors, 2003, 19(1-2): 63-70.
9Coull BM, Malinow MR, Beamer N,et al. Elevated plasma homocysteine concentration as a possible independent risk factor for stroke. Stroke, 1990,21:572-576.
10Sydorskyy Y, Dilworth DJ, Yi EC, et al. Intersection of theK- ap123p-mediated nuclear import and ribosome export pathways [J]. MolCell Biol, 2003, 23(6): 2042-205.
6Makris M. Hyperhomocysteinemia and thrombosis [J]. Clin Lab Haematol, 2000,22(3): 133-134.
7Del Ser T,Barba R,Herranz AS,et al. Hyperhomocysteinemia is a risk factor of secondary vascular events in strok patients [J]. Cerebrovasc Dis, 2001,12(2):91-98.
8Boysen G,Brander T, Cmistensen H, et al. Homocysteine and risk of recurrent stroke [J]. Stroke,2003,34(5):1258-1261.
